Meta Information
ID:bpc-157
Name:BPC-157
Schema Version:1.5
Alternate Names
- Body Protection Compound 157
- Bepecin
Intervention Type
therapeutic_agent
Expected Cost Mean
Low Cost:
120
High Cost:
250
Cost Type:
monthly
Description:
Cost for vials of lyophilized peptide from research chemical suppliers.
Summary
BPC-157 is a synthetic peptide derived from a protein found in gastric juice, primarily investigated for its potent tissue-healing and regenerative properties. Its proposed mechanism involves promoting angiogenesis (new blood vessel formation) and upregulating growth factors, which accelerates the repair of muscle, tendon, ligament, and gut lining. From a healthspan perspective, its value lies in enhancing recovery from injuries, thereby maintaining physical function and mobility, rather than directly targeting core aging pathways.
Purpose
A synthetic peptide that may accelerate tissue repair and recovery.
Card Summary
A synthetic peptide derived from a stomach protein, BPC-157 is primarily used to accelerate healing of tissues like muscle, tendon, and gut by promoting blood vessel growth.
Drug Class
synthetic peptide
Drugs In Class
Empty Array
Impact
Score:
3.8
Justification:
Primarily for acute injury repair, not a direct modulator of core aging pathways.
Evidence
Grade:
C
Score:
2.5
Justification:
Extensive positive animal data but lacks significant human clinical trials for any indication.
Safety
Score:
8.5
Justification:
Unregulated research chemical with no long-term human safety data and variable product purity.
Flags
- Not approved for human consumption by the FDA or other major regulatory bodies.
- Sourced from unregulated 'research chemical' suppliers with potential purity and safety issues.
- Banned by the World Anti-Doping Agency (WADA) as a prohibited substance.
- Long-term effects and safety profile in humans are completely unknown.
- Theoretically, its pro-angiogenic effects could promote the growth of existing undiagnosed cancers.
Verdict
A potent but unproven repair tool; high risk due to unregulated status.
Created
2026-04-24T22:09:05.538843Z
Model
Gemini 3.1 Pro (High)
Delivery
Route:
subcutaneous_injection
Scope:
- systemic
Indication
Focus:
healthspan
Description:
BPC-157 is a synthetic peptide derived from a protein found in gastric juice, primarily investigated for its potent tissue-healing and regenerative properties. Its proposed mechanism involves promotin...
Typical Protocol
- Inject 250-500 mcg subcutaneously once or twice daily for targeted tissue repair.
- Take 500 mcg orally once or twice daily for systemic or gut-related benefits.
- Typically used in short cycles (2-4 weeks) to address specific injuries, not continuously.